Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Molecular and Cellular Biology|August 15, 2003
Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3Vesa Hongisto, Nina Smeds, Stephan Brecht, et al.The Journal of Clinical Psychiatry|September 28, 2010
Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trialStephan Brecht, Durisala Desaiah, Elisete S Marechal, et al.Biochemical Pharmacology|September 6, 2002
The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brainUte Hidding, Kirsten Mielke, Vicki Waetzig, et al.The European Journal of Neuroscience|July 21, 2005
Tumor necrosis factor-alpha receptor 1 (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neuronsJan Wessig, Stephan Brecht, Malte Claussen, et al.Anatomical Record (Hoboken, N.J. : 2007)|September 4, 2009
FK506 protects against various immune responses and secondary degeneration following cerebral ischemiaStephan Brecht, Vicki Waetzig, Ute Hidding, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 2002
c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neuronsEleanor T Coffey, Giedre Smiciene, Vesa Hongisto, et al.The Journal of Clinical Psychiatry|December 7, 2007
Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trialStephan Brecht, Christine Courtecuisse, Catherine Debieuvre, et al.BMJ Open|September 7, 2019
Functional status and life satisfaction of patients with stable angina pectoris in AustriaFabian Spinka, Josef Aichinger, Eva Wallner, et al.Glia|March 2, 2005
c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microgliaVicki Waetzig, Karen Czeloth, Ute Hidding, et al.Cancer Immunology, Immunotherapy : CII|October 3, 2009
Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma modelChristian Ginzkey, Sven O Eicker, Matthias Marget, et al.Pageof 3